ParkerVision remanded to district court after Federal Circuit finds lack of jurisdiction; $440M transmitter damages sought

ParkerVision's appeal was dismissed by the Federal Circuit, which remanded the case to the Middle District of Florida. The company will pursue a jury trial on transmitter patent claims, seeking $440M in damages. The court did not rule on receiver claim construction and denied reassignment to a new judge, according to the company.

Original reporting
Published Oct 1, 2026, 12:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 12:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ParkerVision remanded to district court after Federal Circuit finds lack of jurisdiction; $440M transmitter damages sought — source image
Decision brief

The 30-second read

$PRKRBearishMed
01

Why it matters

The remand and $440M damages request introduce significant legal risk and could depress the share price.

02

Market read

A fresh court decision and sizable damages claim create a material, actionable event for traders.

03

What to watch

Potential appeal outcomes and the separate receiver claim could mitigate overall exposure.

Relevance 8/10Novelty 8/10Timing: today

Background

ParkerVision is involved in a patent dispute with Qualcomm over transmitter technology.

Company-level read

Ticker impact

$PRKRBearishHigh confidence
Context

Federal Circuit remanded ParkerVision v. Qualcomm case and the company seeks $440M in transmitter damages.

Expected impact

potential downward pressure as market prices in the $440M damages exposure

Evidence & confidence

Court remand and high damages request are fresh, material facts that can affect valuation.

Market effects

May affect other firms in the wireless/telecom patent litigation space.

Limited to U.S. equities market where ParkerVision trades.

Low, primarily a company‑specific legal development.

Counterpoint

If the jury finds the damages claim overstated, the stock could rebound.

Key entities

  • ParkerVision Inc.

    Plaintiff in the patent litigation seeking damages.

  • Qualcomm Inc.

    Defendant in the patent litigation.

Related articles

$PRKRLow

ParkerVision Reports Third Quarter 2026 Results

PARKERVISION INC (PRKR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ParkerVision Reports Third Quarter 2026 Results JACKSONVILLE , Fla., November 10, 2026 – ParkerVision, Inc. (OTCQB: PRKR) (“ParkerVision” or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for t

$PRKRMed

ParkerVision Reports Second Quarter 2026 Results

PARKERVISION INC (PRKR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ParkerVision Reports Second Quarter 2026 Results JACKSONVILLE , Fla., August 6, 2026 – ParkerVision, Inc. (OTCQB: PRKR) (“ParkerVision” or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the

$CAPRHighAI 8/10

CAPR Stock Rallies After-Hours As Capricor Reaffirms Deramiocel Confidence Ahead Of Nov. 22 Decision; Says Application In Final Review

Capricor (CAPR) stock rose after-hours as the company reaffirmed confidence in its Deramiocel treatment ahead of a November 22 decision. The HOPE-3 trial met its primary endpoint, showing a 1.1-point improvement in upper limb function. Capricor reported a Q3 net loss of $42.7 million and $198.5 million in cash reserves. Retail sentiment on StockTwits was extremely bullish, with mixed opinions on approval odds. CAPR stock is down 69% year-to-date.